Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Credit Card-Size Microflow System Designed to Tackle Thousands of Experiments

By LabMedica International staff writers
Posted on 27 Aug 2010
Tens of thousands of chemical and biochemical experiments may soon be conducted daily with the use of a microflow system of the size of a credit card. More...
The device has already been tested in research on the effectiveness of antibiotic mixtures.

A group of scientists from the Institute of Physical Chemistry of the Polish Academy of Sciences (IPC PAS; Warsawl), headed by D.Sc. Piotr Garstecki, built a microflow system allowing the streams of drops containing various solutions to merge. The new system makes it possible to produce and precisely control concentrations of reaction micromixtures, and it operates several times faster and with smaller volumes of liquids than the microtitre plate method currently popular at laboratories. "The device developed by us will allow even tens of thousands of biochemical experiments to be conducted daily,” noted Dr. Garstecki. The microlab may considerably affect the way in which experiments are performed with respect to chemical synthesis and medical diagnostics and biotechnologies.

The microflow system constructed in the IPC PAS is a miniature chemical reactor with the size of a credit card. Reactions proceed inside tiny drops moving along specially designed, small channels. Volumes of the drops are controlled with the use of a computer and are typically equal to about one microliter. The system can work at a speed that allows mixing three drops per second. Moreover, instead of micro valves, which it is difficult to construct, scientists used inexpensive typical big valves that they placed outside the device. "Miniaturization of everything is simply not economical. Taking the valves outside the microsystem, the chip itself can be made simple, cheap, and disposable. The most important thing is that the chemical reactions themselves proceed in a microscale under precisely controlled conditions,” explained Krzysztof Churski, a Ph.D. student.

The invention of researchers from the Institute of Physical Chemistry of the PAS already has a potential to influence significantly the development of many areas of chemistry and medicine, in particular screening. Currently, screening is performed with the use of microtiter plates--plates with several hundreds of wells filled in by a robotic handler. In this type of research cost of a single reaction reaches approximately US$3, but the value of reagents is about $0.20; the remaining part is the cost of maintenance of apparatus and its infrastructure. Since in a typical project to search for a new drug the number of tested compounds ranges from several hundreds to as many as several millions, the costs can reach millions of dollars. "Our microflow system not only reduce all costs but also significantly shortens the time necessary to conduct research,” emphasized Dr. Garstecki.

The microflow system from the IPC PAS may be especially useful in searching for new medicines, particularly composed of several antibiotics. Pairs of antibiotics typically have stronger (synergistic pairs) or weaker (antagonistic pairs) effect than each of their components individually. However, it is particularly interesting that certain antagonistic pairs show high effectiveness in fighting microorganisms, which cannot be easily predicted. The existing laboratory methods allow for description of such pairs but demand conducting a huge number of labor-intensive experiments. The apparatus constructed at the IPC PAS can quickly identify the interesting pairs of antibiotics that could prevent one of the basic problems of modern medicine--the creation of drug-resistant strains.

Tests conducted in the Institute of Physical Chemistry of the PAS allowed scientists to demonstrate the operation of the microflow system in the conditions simulating the run of automated screening. Each microdrop merged with two microdrops of antibiotics, chloramphenicol and tetracycline, and the volumes of the former two were altered dynamically, which regulated the proportions between the drugs. The drops mixed in the microflow system were left for three hours in order to incubate bacteria. Then the intensity of light emitted by metabolism markers was analyzed, which allowed vitality of colonies in individual drops to be easily determined. The whole process was automated and revealed that the mixture of the antibiotics examined is the least effective where the proportion of the components is equal.

Microflow techniques are seen as the future of chemical engineering. They go back to the 1990s when the works on the first systems of channels began. At that time, liquids with chemical reagents were let through the channels with diameters of a tenth or hundredth of a millimeter. Where small volumes are used, the flow is laminar and it is subject to effects related to viscosity, which makes it easier to control the run of the reaction (macroscale flows are frequently dominated by inertia and turbulence). Systems producing drops are simple and inexpensive, substances in microchannels mix very well and their flow is usually caused by the difference in pressure, i.e., a physical phenomenon that does not influence the chemical composition of a liquid (contrary to, for instance, flows that are caused by an electric field). In the future, the volume of drops can be reduced to nanoliters or even pictoliters. Many scientists agree that microflow systems will change the nature of modern chemistry as dramatically as integrated circuits changed electronics in the 1970s.

Related Links:

Institute of Physical Chemistry of the Polish Academy of Sciences




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.